Clinical Trial Update: Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cyclophosphamide, pembrolizumab, GVAX Pancreas Vaccine, and SBRT in locally advanced pancreatic cancer has completed and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• GVAX Pancreas Vaccine
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-02-28